ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
39,932.90
0.16%
Gold vs US Dollar
2,409.205
1.30%
Brent Oil
83.415
0.25%
Bitcoin
66,978.37
2.67%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) News

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CERE
DateTimeSourceHeadlineSymbolCompany
08/05/202421:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
18/04/202411:30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
27/02/202421:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
16/02/202421:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202414:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202413:30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202412:44Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202412:19Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CERECerevel Therapeutics Holdings Inc
05/01/202422:13Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
02/01/202423:10PR Newswire (US)Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
28/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
28/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
26/12/202322:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
22/12/202301:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
22/12/202301:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
22/12/202301:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
22/12/202301:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
22/12/202301:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
19/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
15/12/202323:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
11/12/202321:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202322:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202311:23IH Market NewsApple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERE

Your Recent History

LSE
ENET
Ethernity Networks
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
EZJ
Easyjet
LSE
MIN
Minoan
LSE
CUSN
Cornish Metals
LSE
GKP
Gulf Keystone Petroleum
LSE
BIRD
Blackbird
LSE
JLP
Jubilee Metals
LSE
THG
Thg
LSE
AAZ
Anglo Asian Mining
LSE
BP.
Bp
LSE
SRSP
Sirius Petroleum
LSE
CHRY
Chrysalis Investments
LSE
RR.
Rolls-royce
LSE
PXC
Phoenix Copper
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved